InsiderClue
Stocks · Health care · Surgical & Medical Instruments & Apparatus

TriSalus Life Sciences, Inc.

TLSI Clue Score59
United States Fiscal year ends December CIK 0001826667
$4.06 -1.69% Close, 9 Oct 2026
Alert on the numbers Alert on insider trades
Price $4.06 −17.98% Close, 9 Oct 2026

Closing prices at the end of each trading day, from 10 Aug 2023. Not a live quote. Adjusted for share splits, so the line has no step at a split; dividends are not added back.

Revenue and profit

What the business sells, and what is left of it. Point at a year for the detail.
RevenueOperating incomeNet income
Fiscal year 2021Operating income−3.0Net income4.8Fiscal year 2022Revenue12.4Operating income−36.4Net income−47.2 −1,089.8%EPS, diluted−161.55Fiscal year 2023Revenue18.5 +49.3%Operating income−54.5Net income−59.4EPS, diluted−6.77Fiscal year 2024Revenue29.4 +59.0%Operating income−36.2Net income−30.0EPS, diluted−1.31Fiscal year 2025Revenue45.2 +53.4%Operating income−26.9Net income−39.2EPS, diluted−1.84
FY2021FY2022FY2023FY2024FY2025
Revenue n/a 12.4 18.5 29.4 45.2
Growth +49.3% +59.0% +53.4%
Operating income −3.0 −36.4 −54.5 −36.2 −26.9
Net income 4.8 −47.2 −59.4 −30.0 −39.2
Growth −1,089.8%
EPS, diluted n/a −161.55 −6.77 −1.31 −1.84

Margins

How much of each dollar of revenue it keeps. Point at a year for the detail.
Gross marginOperating marginNet margin
Fiscal year 2021Fiscal year 2022Gross margin81.8%Operating margin−293.9%Net margin−380.6%Free cash flow margin−265.9%Fiscal year 2023Gross margin85.9%Operating margin−294.3%Net margin−320.7%Free cash flow margin−276.4%Fiscal year 2024Gross margin86.1%Operating margin−122.9%Net margin−102.1%Free cash flow margin−139.9%Fiscal year 2025Gross margin84.6%Operating margin−59.7%Net margin−86.9%Free cash flow margin−41.9%
FY2021FY2022FY2023FY2024FY2025
Gross margin n/a 81.8% 85.9% 86.1% 84.6%
Operating margin n/a −293.9% −294.3% −122.9% −59.7%
Net margin n/a −380.6% −320.7% −102.1% −86.9%
Free cash flow margin n/a −265.9% −276.4% −139.9% −41.9%

Cash flow

The cash the business makes, what it reinvests, and what it hands back. Point at a year for the detail.
Operating cash flowCapital expenditureFree cash flow
Fiscal year 2021Operating cash flow−1.7Fiscal year 2022Operating cash flow−32.3Capital expenditure−0.7Free cash flow−33.0Buybacks−232.4Fiscal year 2023Operating cash flow−50.6Capital expenditure−0.6Free cash flow−51.2Fiscal year 2024Operating cash flow−40.8Capital expenditure−0.3Free cash flow−41.2Fiscal year 2025Operating cash flow−18.0Capital expenditure−0.9Free cash flow−18.9
FY2021FY2022FY2023FY2024FY2025
Operating cash flow −1.7 −32.3 −50.6 −40.8 −18.0
Capital expenditure n/a −0.7 −0.6 −0.3 −0.9
Free cash flow n/a −33.0 −51.2 −41.2 −18.9
Growth
Buybacks n/a −232.4 n/a n/a n/a

Balance sheet

What it holds against what it owes, at each year end. Point at a year for the detail.
CashTotal debt
Fiscal year 2021Cash0.2Shareholders’ equity−129.6Fiscal year 2022Cash9.4Shareholders’ equity−177.1Fiscal year 2023Cash11.8Total debt0.0Net cash (debt)11.8Shareholders’ equity−27.1Fiscal year 2024Cash8.5Total debt22.1Net cash (debt)−13.6Shareholders’ equity−25.9Fiscal year 2025Cash20.4Total debt33.0Net cash (debt)−12.6Shareholders’ equity−33.9
FY2021FY2022FY2023FY2024FY2025
Cash 0.2 9.4 11.8 8.5 20.4
Total debt n/a n/a 0.0 22.1 33.0
Net cash (debt) n/a n/a 11.8 −13.6 −12.6
Shareholders’ equity −129.6 −177.1 −27.1 −25.9 −33.9

In millions of USD, except per-share figures and ratios. Fiscal years, as last filed with the SEC.

Financial statements FY2025 · 10-K

Ratios

Percentages worked out from the filed figures; debt to equity in times. Fiscal years ending December, each column as last filed with the SEC.
Click a line to chart it
Fiscal year FY2021 31 Dec 2021 FY2022 31 Dec 2022 FY2023 31 Dec 2023 FY2024 31 Dec 2024 FY2025 31 Dec 2025
Margins
n/a 81.8% 85.9% 86.1% 84.6%
n/a −293.9% −294.3% −122.9% −59.7%
n/a −380.5% −320.6% −102.1% −86.9%
n/a −380.6% −320.7% −102.1% −86.9%
n/a −265.9% −276.4% −139.9% −41.9%
Spending
n/a 172.3% 161.2% 60.1% 33.1%
n/a 100.7% 127.0% 61.0% 47.5%
n/a 5.3% 3.2% 1.2% 2.0%
0.0% n/a n/a n/a n/a
Returns
1.9% −214.5% −241.3% −125.3% −111.0%
Balance and payout
6.9% 156.0% 210.0% 208.0% 195.8%